Bottom line
Is HEAL a good fund? The bottom line
HEAL is an actively managed technology sector ETF from Global X.
Its expense ratio is 0.5% — about $50 a year on every $10,000 invested, cheaper than 77% of technology sector funds we track.
It returned −1.0% over one year, −12.7% a year over five years (as of Dec 31, 2025, per its prospectus).
With $25.0 million in net assets and 41 holdings, its largest position is Dexcom, Inc. (4.9%) and the top 10 make up 43% of the portfolio.
What stands out
- Low cost: cheaper than 77% of technology sector peers
What to watch
- 5-year return in the bottom quarter of its category
- Small fund ($25.0 million) — small funds are likelier to close
Updated Nov 19, 2026
What HEAL invests in
"The Global X HealthTech ETF (the ""Fund"") seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index (the ""Underlying Index"")."
"The Fund invests at least 80% of its total assets, plus borrowings for investment purposes (if any), in the securities of the Global X HealthTech Index (the ""Underlying Index"") and in American Depositary Receipts (""ADRs"") and Global Depositary Receipts (""GDRs"") based on the securities in the Underlying Index. The Fund's 80% investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Fund may lend securities representing up to one-third of the value of the Funds total assets (including the value of the collateral received). The Underlying Index is owned and was developed by Global X Management Company LLC (the Index Provider), an affiliate of the Fund and the Fund's investment adviser (the Adviser). The Underlying Index is administered and calculated by Mirae Asset Global Indices Pvt. Ltd. (the Index Administrator)…
From the fund's prospectus (filed Mar 27, 2026).
HEAL performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HEAL | −1.0% | −12.7% | — |
| Technology Sector median | +24.0% | +10.0% | +16.7% |
Source: Fund prospectus, as of Dec 31, 2025
What HEAL costs
On a $10,000 investment, HEAL's 0.5% expense ratio costs about $50 a year. The prospectus estimates $628 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.
HEAL top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Dexcom, Inc. | 4.89% |
| 2 | Iqvia Holdings Inc | 4.72% |
| 3 | Oscar Health, Inc. | 4.61% |
| 4 | Fidelity Colchester Str Tr Money Mkt Gov Port | 4.46% |
| 5 | Ge Healthcare Technologies Inc. | 4.17% |
| 6 | Veeva Systems Inc. | 4.13% |
| 7 | Koninklijke Philips N.V. | 4.12% |
| 8 | Masimo Corporation | 4.07% |
| 9 | Pro Medicus Ltd | 3.96% |
| 10 | Hims & Hers Health, Inc. | 3.90% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 43% of the fund. See all top 25 holdings and asset mix →